Lanzamiento Enero 2027

Ensayo controlado aleatorizado2018Alimentación controlada

β-Cryptoxanthin and zeaxanthin are highly bioavailable from whole-grain and refined biofortified orange maize in humans with optimal vitamin A status: a randomized, crossover, placebo-controlled trial

Titcomb TJ, Sheftel J, Sowa M, Gannon BM, Davis CR, Palacios-Rojas N, Tanumihardjo SA

The American journal of clinical nutrition · 8 citas

Etiquetas de revisión

Alimentación controlada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
Bill and Melinda Gates Foundation
Gobierno
National Institute of Diabetes and Digestive and Kidney Diseases
Gobierno
NIDDK NIH HHS
Subvenciones
Bill and Melinda Gates Foundation (OPP27510); National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007665)

Según 3 financiadores declarados.

Publicación

Publicado
2018-10-01 · Am J Clin Nutr · vol. 108 · número 4 · págs. 793–802
Editorial
Elsevier BV
Citado
21 citas · más que el 84% de estudios similares · 1.6× el promedio de su campo
Referencias
51 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Plant Micronutrient Interactions and Effects · Antioxidant Activity and Oxidative Stress · Phytochemicals and Antioxidant Activities
Palabras clave
beta-cryptoxanthin, zeaxanthin, biofortified maize, orange maize, carotenoid bioavailability, vitamin A status, serum retinol, xanthophylls, vitamin A deficiency, carotenoid absorption
MeSH
liver, humans, zea mays, vitamin a deficiency, carbon isotopes, beta carotene, vitamin a, diet, cross-over studies, feeding behavior, biological availability, nutritional status, bread, food, fortified, adult, africa, female, male, young adult, zeaxanthins, biomarkers, whole grains, beta-cryptoxanthin, provitamins

7 autores

  • Tyler J. Titcomb🇺🇸University of Wisconsin–Madison
  • Jesse Sheftel🇺🇸University of Wisconsin–Madison
  • Margaret Sowa🇺🇸University of Wisconsin–Madison
  • Bryan M Gannon🇺🇸University of Wisconsin–Madison
  • Christopher R. Davis🇺🇸University of Wisconsin–Madison
  • Natalia Palacios‐Rojas🇲🇽Centro Internacional de Mejoramiento de Maíz Y Trigo
  • Sherry Ann Tanumihardjo🇺🇸 · autor de correspondenciaUniversity of Wisconsin–Madison

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Biofortification of staple crops with β-carotene is a strategy to reduce vitamin A deficiency, and several varieties are available in some African countries. β-Cryptoxanthin (BCX)-enhanced maize is currently in field trials. To our knowledge, maize BCX bioavailability has not been assessed in humans. Serum retinol 13C content and xanthophyll concentrations are proposed effectiveness biomarkers for biofortified maize adoption.

Objective

We determined the relative difference in BCX and zeaxanthin bioavailability from whole-grain and refined BCX-biofortified maize during chronic feeding compared with white maize and evaluated short-term changes in 13C-abundance in serum retinol.

Design

After a 7-d washout, 9 adults (mean ± SD age: 23.4 ± 2.3 y; 5 men) were provided with muffins made from BCX-enhanced whole-grain orange maize (WGOM), refined orange maize (ROM), or refined white maize (RWM) for 12 d in a randomized, blinded, crossover study followed by a 7-d washout. Blood was drawn on days 0, 3, 6, 9, 12, 15, and 19. Carotenoid areas under the curve (AUCs) were compared by using a fixed-effects model. 13C-Abundance in serum retinol was determined by using gas chromatography/combustion/isotope-ratio mass spectrometry on days 0, 12, and 19. Vitamin A status was determined by 13C-retinol isotope dilution postintervention.

Results

The serum BCX AUC was significantly higher for WGOM (1.70 ± 0.63 μmol ⋅ L-1 ⋅ d) and ROM (1.66 ± 1.08 μmol ⋅ L-1 ⋅ d) than for RWM (-0.06 ± 0.13 μmol ⋅ L-1 ⋅ d; P < 0.003). A greater increase occurred in serum BCX from WGOM muffins (131%) than from ROM muffins (108%) (P ≤ 0.003). Zeaxanthin AUCs were higher for WGOM (0.94 ± 0.33) and ROM (0.96 ± 0.47) than for RWM (0.05 ± 0.12 μmol ⋅ L-1 ⋅ d; P < 0.003). The intervention did not affect predose serum retinol 13C-abundance. Vitamin A status was within an optimal range (defined as 0.1-0.7 μmol/g liver).

Conclusions

BCX and zeaxanthin were highly bioavailable from BCX-biofortified maize. The adoption of BCX maize could positively affect consumers' BCX and zeaxanthin intakes and associated health benefits. This trial is registered at www.clinicaltrials.gov as NCT02800408.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.